Literature DB >> 19763437

Soluble epidermal growth factor receptor: a biomarker of epithelial ovarian cancer.

Andre T Baron1, Jacqueline M Lafky, Cecelia H Boardman, Elsa M Cora, Marites C Buenafe, Dachao Liu, Alfred Rademaker, David A Fishman, Karl C Podratz, Jill L Reiter, Nita J Maihle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19763437     DOI： 10.1007/978-0-387-98094-2_9

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN： 0927-3042


× No keyword cloud information.
  7 in total

1.  A phase II evaluation of gefitinib in the treatment of persistent or recurrent endometrial cancer: a Gynecologic Oncology Group study.

Authors:  Kimberly K Leslie; Michael W Sill; Edgar Fischer; Kathleen M Darcy; Robert S Mannel; Krishnansu S Tewari; Parviz Hanjani; Jason A Wilken; Andre T Baron; Andrew K Godwin; Russell J Schilder; Meenakshi Singh; Nita J Maihle
Journal:  Gynecol Oncol       Date:  2013-02-21       Impact factor: 5.482

2.  Identification of potential glycan cancer markers with sialic acid attached to sialic acid and up-regulated fucosylated galactose structures in epidermal growth factor receptor secreted from A431 cell line.

Authors:  Shiaw-Lin Wu; Allen D Taylor; Qiaozhen Lu; Samir M Hanash; Hogune Im; Michael Snyder; William S Hancock
Journal:  Mol Cell Proteomics       Date:  2013-01-31       Impact factor: 5.911

3.  Optimizing molecular-targeted therapies in ovarian cancer: the renewed surge of interest in ovarian cancer biomarkers and cell signaling pathways.

Authors:  Donavon Hiss
Journal:  J Oncol       Date:  2012-02-06       Impact factor: 4.375

4.  EGFR soluble isoforms and their transcripts are expressed in meningiomas.

Authors:  Angélique Guillaudeau; Karine Durand; Barbara Bessette; Alain Chaunavel; Isabelle Pommepuy; Fabrice Projetti; Sandrine Robert; François Caire; Hélène Rabinovitch-Chable; François Labrousse
Journal:  PLoS One       Date:  2012-05-18       Impact factor: 3.240

5.  Evaluation of serum epidermal growth factor receptor (EGFR) in correlation to circulating tumor cells in patients with metastatic breast cancer.

Authors:  Malgorzata Banys-Paluchowski; Isabell Witzel; Sabine Riethdorf; Brigitte Rack; Wolfgang Janni; Peter A Fasching; Erich-Franz Solomayer; Bahriye Aktas; Sabine Kasimir-Bauer; Klaus Pantel; Tanja Fehm; Volkmar Müller
Journal:  Sci Rep       Date:  2017-12-11       Impact factor: 4.379

Review 6.  Prediction of the treatment response in ovarian cancer: a ctDNA approach.

Authors:  Mina Sharbatoghli; Somayeh Vafaei; Hamidreza Aboulkheyr Es; Mohsen Asadi-Lari; Mehdi Totonchi; Zahra Madjd
Journal:  J Ovarian Res       Date:  2020-10-19       Impact factor: 4.234

7.  Effect of cholesterol-lowering agents on soluble epidermal growth factor receptor level in type 2 diabetes and hypercholesterolemia.

Authors:  Jun Choul Lee; Kyong Hye Joung; Ji Min Kim; Seon Mee Kang; Hyun Jin Kim; Bon Jeong Ku
Journal:  Medicine (Baltimore)       Date:  2022-08-26       Impact factor: 1.817
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.